<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01607970</url>
  </required_header>
  <id_info>
    <org_study_id>OXT-168/11</org_study_id>
    <nct_id>NCT01607970</nct_id>
  </id_info>
  <brief_title>Oxytocin Modulation of Startle Reactivity to Social Stimuli and Moral Decision Making</brief_title>
  <official_title>Double-blind, Placebo-controlled, Randomized Study: Oxytocin Modulation of Startle Reactivity to Social Stimuli and Moral Decision Making</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bonn</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bonn</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether oxytocin affects the modulation of startle
      reactivity by aversive social stimuli and to investigate the oxytocin effect on moral
      judgements. Furthermore the investigators explore the effects of oxytocin receptor (OXTR)
      polymorphisms on behavioral responses to social stimuli.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The neuropeptide oxytocin (OXT) can enhance the impact of positive social cues but may reduce
      that of negative ones, although it is unclear whether the latter causes blunted emotional
      responses. After OXT or placebo application participants are exposed to acoustic startle
      probes presented alone and during viewing of 60 color pictures mostly selected from the
      'International Affective Picture System'. The paradigm featured 20 negative (mostly
      threatening), 20 neutral, and 20 positive pictures, presented for 5 s each. In the other part
      of the experiment, after intranasal OXT or placebo application participants respond to 60
      moral dilemmas.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>baseline startle magnitude and affective modulation of the startle magnitude after oxytocin and placebo administration</measure>
    <time_frame>24 Months</time_frame>
    <description>The experimental tasks started 45 min after intranasal OXT/PLC administration. The STARTLE-paradigm features 20 negative (mostly threatening), 20 neutral, and 20 positive pictures, presented for 5 s each. The startle stimulus consists of a single 50-ms burst of white noise (100 dB) with nearly instantaneous rise and was delivered binaurally via headphones during 60% of the pictures (i.e. 12 from each category) at 2 - 4 s after picture onset. We examined the baseline startle magnitude as well as the affective modulation of the startle magnitude.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>moral decision making after oxytocin and placebo administration</measure>
    <time_frame>24 months</time_frame>
    <description>The experimental tasks started 45 min after OXT/PLC administration. The moral dilemmas performed in the present study were identical to those published previously by Greene et al.(2001).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>oxytocin receptor (OXTR) polymorphism and correlation with social behavior</measure>
    <time_frame>24 months</time_frame>
    <description>OXTR genotyping, social behavior testing</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Healthy Male Volunteers</condition>
  <arm_group>
    <arm_group_label>Oxytocin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>24 IU Oxytocin, intranasal application 45 min prior to the experiment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>intranasal application, sodium chloride solution, 3 puffs per nostril</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxytocin</intervention_name>
    <description>Oxytocin: 24 IU; 3 puffs per nostril, each with 4 IU OXT</description>
    <arm_group_label>Oxytocin</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Oxytocin: Syntocinon-Spray, Novartis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male volunteers

        Exclusion Criteria:

          -  Current or past psychiatric disease

          -  Current or past physical illness

          -  Psychoactive medication

          -  Tobacco smokers
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rene Hurlemann, MSc MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Psychiatry, University of Bonn, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Psychiatry, University of Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://renehurlemann.squarespace.com/welcome/</url>
    <description>Click here for more information about the NEMO research group</description>
  </link>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2012</study_first_submitted>
  <study_first_submitted_qc>May 25, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 30, 2012</study_first_posted>
  <last_update_submitted>May 25, 2012</last_update_submitted>
  <last_update_submitted_qc>May 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 30, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Bonn</investigator_affiliation>
    <investigator_full_name>Rene Hurlemann</investigator_full_name>
    <investigator_title>MSc MD PhD</investigator_title>
  </responsible_party>
  <keyword>Oxytocin</keyword>
  <keyword>Startle</keyword>
  <keyword>moral dilemma</keyword>
  <keyword>oxytocin receptor gene</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

